ChM-1 Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of ChM-1 monoclonal antibodies for investigating ChM-1 in various biological processes. ChM-1 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ChM-1, also known as cartilage matrix protein, plays a crucial role in cartilage development and maintenance, making it essential for skeletal health. ChM-1 is involved in the regulation of chondrocyte function and the extracellular matrix, contributing to the integrity of cartilage tissue. Understanding ChM-1 function is vital for elucidating mechanisms underlying cartilage-related diseases, such as osteoarthritis. Research focused on ChM-1 continues to reveal new insights into cartilage biology and potential therapeutic approaches. Investigating ChM-1 expression patterns helps researchers better understand skeletal development and disease progression. Santa Cruz Biotechnology monoclonal antibodies for ChM-1 enable researchers worldwide to advance scientific understanding of cartilage biology and contribute to the development of new therapeutic strategies.